Charles River Laboratories International (CRL)
(Real Time Quote from BATS)
$207.44 USD
+0.73 (0.35%)
Updated Jun 27, 2024 01:16 PM ET
3-Hold of 5 3
B Value C Growth B Momentum B VGM
Brokerage Reports
Charles River Laboratories International, Inc. [CRL]
Reports for Purchase
Showing records 321 - 340 ( 384 total )
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Investing for the Future; Raising PT to $140
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
2018 Investor Day Lays Out Medium-Term Growth Roadmap
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Organic Growth Outlook Improving; Increasing PT to $126
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Tech Morning Call
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Initiating Coverage on Charles River Laboratories with a Neutral Rating and $115 PT
Provider: Mitsubishi UFG Securities (USA)
Analyst: TWIZELL J
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Company: Charles River Laboratories International, Inc.
Industry: Medical Services
Morning Call
Provider: KEYBANC CAPITAL MARKETS